Literature DB >> 824227

Deformities of the spine in neurofibromatosis. Clinical and radiographic study of 46 cases.

R Savini, G Vicenzi.   

Abstract

Scoliosis, in particular kyphoscoliosis, is the most frequent bony abnormality in neurofibromatosis (up to 43 per cent). The most usually accepted aetiopathogenesis is a primary mesoblastic defect of the vertebrae, though other hypotheses exist. Hereditary factors have been shown to be present in about half the cases and the spinal deformity is almost always associated with skin changes, and less frequently with nerve or cardiac changes or with elefantiasis. The ages most affected are from four to eleven years, the commonest site is the dorsal spine and the average number of affected vertebrae is 5.5. There are three main radiological characteristics: widening of the spinal canal, widening of the intervertebral foraminae, and a scalloped appearance of the posterior borders of the vertebral bodies. From the point of view of prognisis the scoliosis is markedly progressive and difficult to control, even after bone maturity. In consequence, neurological symptoms frequently arise, usually as late complications.

Entities:  

Mesh:

Year:  1976        PMID: 824227

Source DB:  PubMed          Journal:  Ital J Orthop Traumatol        ISSN: 0390-5489


  3 in total

1.  Surgical correction of severe dystrophic neurofibromatosis scoliosis: an experience of 32 cases.

Authors:  Wael Koptan; Yasser ElMiligui
Journal:  Eur Spine J       Date:  2010-05-27       Impact factor: 3.134

2.  Case report 343. Neurofibroma arising in sympathetic ganglion with probable associated spinal neuroarthropathy (presumptive diagnosis).

Authors:  D J Sartoris; H Jones
Journal:  Skeletal Radiol       Date:  1986       Impact factor: 2.199

Review 3.  Dystrophic kyphoscoliosis in neurofibromatosis type I: a report of two cases and review of the literature.

Authors:  J Vandenbroucke; A van Ooy; C Geukers; A J van der Linden; M Hoogmartens
Journal:  Eur Spine J       Date:  1997       Impact factor: 3.134

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.